HRTX - HERON THERAPEUTICS, INC. /DE/
IEX Last Trade
1.52
-0.015 -0.987%
Share volume: 9,181
Last Updated: Fri 27 Dec 2024 05:29:49 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$1.54
-0.02
-0.98%
Summary score
24%
Profitability
25%
Dept financing
7%
Liquidity
66%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-30.63%
Return on assets
-22.23%
Return on sales
-578.63%
Return on invested capital
94.53%
Total debt ratio
41.68%
Debt ratio change over timeo
-0.6%
Current Ratio
3.94%
Quick Ratio
3.68%
Cash Position Ratio
1.03%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.31%
Return on assets
-11.08%
Return on sales
-176.13%
Return on invested capital
84.39%
Total debt ratio
24.35%
Debt ratio change over timeo
-0.67%
Current Ratio
4.37%
Quick Ratio
4.04%
Cash Position Ratio
0.83%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-17.03%
Return on assets
-12.88%
Return on sales
-245.94%
Return on invested capital
104.48%
Total debt ratio
25.11%
Debt ratio change over time
-0.73%
Current Ratio
4.24%
Quick Ratio
3.79%
Cash Position Ratio
0.87%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-132.33%
Return on assets
-121.54%
Return on sales
-597.15%
Return on invested capital
0.91%
Total debt ratio
-59.82%
Debt ratio change over time
-0.6%
Current Ratio
4.04%
Quick Ratio
3.71%
Cash Position Ratio
0.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -30.63% | -3.05% | 11.55% | 6.27% |
| Return on assets | -22.23% | 3.6% | 3.57% | 5.27% |
| Return on sales | -578.63% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 94.53% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 69% | 62% |
| Total debt ratio | 41.68% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.6% | 6.09% | 6.03% | 1.53% |
| Dept financing | 10% | 50% | 43% | 14% |
| Current Ratio | 4.37% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 4.04% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.83% | 1.48% | 0.76% | 1.49% |
| Liquididy | 70% | 33% | 57% | 69% |
| Short-term ratios | HRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.31% | -25.62% | 17.94% | 7.14% |
| Return on assets | -11.08% | 3.26% | 3.67% | 4.71% |
| Return on sales | -176.13% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 84.39% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 41% | 72% | 63% |
| Total debt ratio | 24.35% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.67% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 4.37% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 4.04% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.83% | 1.48% | 0.76% | 1.49% |
| Liquididy | 64% | 49% | 35% | 63% |